| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/25/2004 | CN1523999A DNA expression vectors and methods of use |
| 08/25/2004 | CN1523105A Serine proteinase and coded sequence thereof |
| 08/25/2004 | CN1523039A Monoclonal antibody GDK-1 of anti-cell membrane glucoprotein KD-43 and its iodide DGDK-1 and application |
| 08/25/2004 | CN1163754C Method for diagnosing a patient for chlamydia |
| 08/25/2004 | CN1163599C Anti-GPIIB/IIIA recombination antibody |
| 08/25/2004 | CN1163512C Humanized neutralizing genetic engineering Fab antibody of anti hepatitis A virus |
| 08/25/2004 | CN1163511C Yolk anti-interleukin -8 antibody, preparation method and its application |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/25/2004 | CN1163506C Novel human cell factor and its coding sequence and use |
| 08/25/2004 | CN1163503C Virus clearance process |
| 08/25/2004 | CN1163489C Human gamma globulin affinity ligand and its use |
| 08/25/2004 | CN1163272C Application of TNF antagonists as medicaments for treating septic diseases |
| 08/24/2004 | US6780978 Fluorescence-activating antisera and IgG fraction therefrom |
| 08/24/2004 | US6780975 Long wavelength engineered fluorescent proteins |
| 08/24/2004 | US6780971 Compositions for inhibiting the aggregation pathway of α-synuclein |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780837 Administering neurotrophic factor prior to, during or after damaging light exposure |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780613 For identifying active domains and amino acid residues in polypeptides; prolactins; placental lactogens |
| 08/24/2004 | US6780611 G protein coupled receptors; drug screening |
| 08/24/2004 | US6780603 Altering gene expression for diagnosis |
| 08/24/2004 | US6780419 Isolated polypeptide comprising specified amino acid sequence or immunogenic fragment of at least 15 contiguous amino acids, which when administered to subject induces antibody or t-cell mediated immune response that recognizes polypeptide |
| 08/24/2004 | US6780418 Sequentially incubating with sample containing cells of taxa actinomycetes thiol-selective reagent producing maleimidyl derivatives, purified polyclonal antibody binding to maleimidyl derivative, and reagent detecting antibody binding |
| 08/24/2004 | US6780416 Bee venom polypeptides and methods of use thereof |
| 08/24/2004 | US6780413 Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders |
| 08/24/2004 | US6780412 Protein and monoclonal antibody specific thereto |
| 08/24/2004 | CA2458824A1 Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to venezuelan equine encephalitis virus |
| 08/19/2004 | WO2004070385A1 A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual |
| 08/19/2004 | WO2004070025A2 Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 08/19/2004 | WO2004070012A2 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | WO2004070011A2 HIGH AFFINITY ANTI-HUMAN IgE ANTIBODIES |
| 08/19/2004 | WO2004070010A2 A method for generating high affinity antibodies |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069875A2 Immunoglobulin anti integrin |
| 08/19/2004 | WO2004069874A1 Monoclonal antibodies against the ring surface protein 2 (rsp-2) antigen of plasmodium falciparum |
| 08/19/2004 | WO2004069873A2 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 08/19/2004 | WO2004069872A1 Human heavy chain antibody expression in filamentous fungi |
| 08/19/2004 | WO2004069860A2 Isg15-conjugated proteins |
| 08/19/2004 | WO2004069184A2 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | WO2004069183A2 Immune regulation based on the targeting of early activation molecules |
| 08/19/2004 | WO2004069182A2 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | WO2004069173A2 Methods for modulating an inflammatory response |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004069159A2 Vitamin receptor binding drug delivery conjugates |
| 08/19/2004 | WO2004069140A2 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 08/19/2004 | WO2004068931A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | WO2004058821A3 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
| 08/19/2004 | WO2004052920A9 Conversion of apoptotic proteins |
| 08/19/2004 | WO2004048414A3 Holo-transcobalamins binding partners and their use in cobalamin assay |
| 08/19/2004 | WO2004046186A3 Intrabodies against the oncogenic form of ras |
| 08/19/2004 | WO2004033628A3 Use of monoclonal antibodies to distinguish protein conformational isoforms |
| 08/19/2004 | WO2004029583A3 Methods of secretory vimentin detection and modulation |
| 08/19/2004 | WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases |
| 08/19/2004 | WO2003090600A3 Compositions and methods for the diagnosis and treatment of tumor |
| 08/19/2004 | WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 08/19/2004 | WO2003072720A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 08/19/2004 | WO2003068799A3 Oligomeric molecules and uses thereof |
| 08/19/2004 | WO2003057134A8 Specific binding agents of human angiopoietin-2 |
| 08/19/2004 | WO2003049117A3 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 08/19/2004 | US20040163140 Biological material |
| 08/19/2004 | US20040163137 PG-3 and biallelic markers thereof |
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162414 Method for reducing or preventing modification of a polypeptide in solution |
| 08/19/2004 | US20040162413 Methods of optimizing antibody variable region binding affinity |
| 08/19/2004 | US20040162411 Potent T cell modulating molecules |
| 08/19/2004 | US20040162236 Providing a sample; introducing the sample to an antibody that binds immunospecifically to the polypeptide (containing amino acids from 1 to 82 ); and determining the presence or amount of antibody bound to said polypeptide, thus determining the presence or amount of polypeptide in the sample |
| 08/19/2004 | US20040161858 TNF binding ligands and antibodies |
| 08/19/2004 | US20040161840 Bax-Responsive genes for drug target identification in yeast and fungi |
| 08/19/2004 | US20040161825 Sperm specific proteins |
| 08/19/2004 | US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161810 for detection/quantitative analysis; serpins (serine proteinase inhibitors); enzyme-linked immunosorbent assay (ELISA); genetic engineering |
| 08/19/2004 | US20040161776 Mixture comprising multimeric prostate specific membrane antigen (PSMA) for use as tools in diagnosis and treatment of cell proliferative disorders |
| 08/19/2004 | US20040161762 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/19/2004 | US20040161757 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 08/19/2004 | US20040161745 Nucleotide sequences coding glucuronidase for identifying modulators for treatment of inflammation; wound healing agents and tissue repair |
| 08/19/2004 | US20040161739 HIV diagnostic methods |
| 08/19/2004 | US20040161738 Using endothelial cells to isolate and recover phage which preferentially bind blood-brain barrier proteins; for use as drug targeting tool in treating brain disorders; drug delivery; tissue targeted therapy |
| 08/19/2004 | US20040161429 Safe and effective vascular targeting, angiogenesis inhibiting and tumor treatment using single component antibody based therapeutics that bind to anionic phospholipids |
| 08/19/2004 | US20040161427 Immunogen adherence and method of making and using same |
| 08/19/2004 | US20040161426 Use of IL-6 antagonists in combination with steroids to enhance apoptosis |
| 08/19/2004 | US20040161425 Chemokine receptor antagonists as therapeutic agents |
| 08/19/2004 | CA2519012A1 A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2515081A1 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | CA2514841A1 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | CA2514840A1 High affinity anti-human ige antibodies |
| 08/19/2004 | CA2514839A1 A method for generating high affinity antibodies |
| 08/19/2004 | CA2514834A1 Human heavy chain antibody expression in filamentous fungi |
| 08/19/2004 | CA2514641A1 Methods for modulating an inflammatory response |
| 08/19/2004 | CA2514576A1 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2514270A1 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 08/19/2004 | CA2513905A1 Immune regulation based on the targeting of early activation molecules |
| 08/19/2004 | CA2513722A1 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | CA2512867A1 Vitamin receptor binding drug delivery conjugates |
| 08/19/2004 | CA2512051A1 Immunoglobulin |
| 08/18/2004 | EP1447448A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 08/18/2004 | EP1447093A1 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |